Position in LLY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$57,311,169
+$23,444,318 QoQ
Shares Held
47,782
+29.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
1.76%
of 13F equity value
Holder Rank
#511
of 4,605 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Dakota Wealth Management holds $173,563,596 across 12 Drug Manufacturers - General names. LLY ranks #1 (33.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
47,782 | $57,311,169 | |
| 2 | MRK |
Merck & Co., Inc.
|
250,026 | $32,128,341 | |
| 3 | JNJ |
Johnson & Johnson
|
98,608 | $25,043,473 | |
| 4 | AMGN |
Amgen Inc
|
48,550 | $17,580,926 | |
| 5 | ABBV |
AbbVie Inc.
|
53,370 | $13,430,026 | |
| 6 | BIIB |
Biogen Inc.
|
47,326 | $10,225,255 | |
| 7 | PFE |
Pfizer Inc
|
390,045 | $9,392,283 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
41,150 | $5,198,891 |
All Filings in LLY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $57,311,169 | 47,782 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $33,866,851 | 36,821 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $32,441,368 | 30,187 | Shares | Defined | 2026-01-13 | |
| 2025-09-30 | $25,327,785 | 33,195 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $28,560,420 | 36,638 | Shares | Defined | 2025-07-16 | |
| 2025-03-31 | $33,014,926 | 39,974 | Shares | Defined | 2025-05-02 | |
| 2024-12-31 | $43,347,028 | 56,149 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $51,368,573 | 57,982 | Shares | Defined | 2024-10-23 | |
| 2024-06-30 | $53,249,924 | 58,815 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $45,471,762 | 58,450 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $25,439,794 | 43,642 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $23,444,112 | 43,647 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $22,946,253 | 48,928 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $15,921,638 | 46,362 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $15,520,395 | 42,424 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $11,061,479 | 34,209 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $12,563,912 | 38,750 | Shares | Other | 2022-08-05 | |
| 2022-03-31 | $11,515,510 | 40,212 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $11,706,479 | 42,381 | Shares | Other | 2022-02-10 | |
| 2021-09-30 | $6,913,015 | 29,920 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $1,955,969 | 8,522 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,369,764 | 7,332 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,343,966 | 7,960 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||